Gentherm (THRM) Q1 2026 Earnings Transcript

Gentherm reported Q1 revenue of $394 million, up 11.3% year over year and a quarterly record, with adjusted EBITDA of $49.3 million (12.5% margin) and adjusted EPS of $0.84, up 65%. The company reaffirmed full-year guidance of $1.5 billion-$1.6 billion in revenue and $175 million-$195 million in adjusted EBITDA, but warned of about $20 million in annualized inflationary/logistics cost pressure and depressed margins in Q2-Q3 due to delayed cost recovery. Strategic positives include $395 million of new automotive awards, progress on the Modine Performance Technologies merger, and new growth initiatives in home/office and medical markets.

Analysis

THRM looks like a classic “good quarter, worse next two quarters” setup. The market will likely anchor on the record revenue and margin beat, but the real driver of the stock is whether management can reprice inflation fast enough to avoid a Q2/Q3 earnings air pocket. Because the cost shock is gross, while recovery is negotiated and lagged, the near-term issue is less absolute inflation than working-capital and timing drag that can temporarily compress incremental margins even if demand stays healthy.

The second-order winner is the company’s scale and product mix, not just the automotive segment. China launch momentum and the furniture/medical ramps create an internal hedge against light-vehicle cyclicality, and that matters because the next 12 months are likely to reward names with multiple demand pools more than pure EV/ICE beta. The Modine deal is also strategically important: it gives THRM a broader thermal platform, but the real financial upside is the operating playbook transfer — if management can export Modine-like discipline, the $10M OpEx run-rate benefit is probably the more immediate lever than revenue synergies.

The risk is that investors overestimate the speed of recovery on the inflation pass-through. If customer negotiations slip into late Q3, consensus 2026 EBITDA likely proves too high even if annual revenue holds, because the company is guiding to a compressed margin profile exactly when the street will be trying to model a clean second-half rebound. On the other hand, the setup could reverse quickly if freight normalizes and commercial recovery lands early; in that case, the stock rerates on visible margin inflection rather than top-line growth.

The contrarian view is that the market may be underappreciating how much of the current weakness is self-inflicted, not structural. A leaner org, better asset utilization, and non-auto launches can produce a much steeper earnings trajectory in 2027 than the guide implies, especially with leverage near zero. But that’s a 6-12 month story; into the next two quarters, this is still a timing-and-execution trade, not a clean fundamental breakout.

Key Decisions for Investors

• Short-term: avoid chasing THRM post-print; wait for a better entry after Q2 guidance reset risk or buy only on a 10-15% pullback if customer pass-through progress is visible.
• Pair trade: long THRM / short GM for 3-6 months if you want automotive content exposure with better mix shift and less EV program noise; THRM has cleaner idiosyncratic growth and balance-sheet optionality.
• For event-driven accounts, sell THRM downside via put spreads into the next 60-90 days; the implied air pocket from Q2/Q3 margin compression should keep skew elevated, while outright collapse risk is limited by liquidity and low leverage.
• If you want to express the inflation/cost-pass-through theme more directly, pair long THRM with short a freight/material-sensitive industrial supplier lacking pricing power; THRM should outperform once the market distinguishes temporary timing pressure from permanent margin loss.
• Catalyst watch: add THRM only if by late Q2 management shows concrete customer repricing wins or if Modine integration milestones tighten the 2027 margin narrative; absent that, the stock likely trades sideways to down despite good strategic headlines.